HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Increased interferon alpha receptor 2 mRNA levels is associated with renal cell carcinoma metastasis.

AbstractBACKGROUND:
Interferon-alpha (IFN-alpha) is one of the central agents in immunotherapy for renal cell carcinoma (RCC) and binds to the IFN-alpha receptor (IFNAR). We investigated the role of IFNAR in RCC.
METHODS:
We quantified IFNAR mRNA expression in paired tumor and non-tumor samples from the surgical specimens of 103 consecutive patients with RCC using a real-time reverse transcription polymerase chain reaction (RT-PCR), and IFNAR2 protein using Western blotting.
RESULTS:
The absolute level of IFNAR1 and IFNAR2 mRNAs in tumor and non-tumor tissues did not correlate with the malignant and metastatic profiles. The relative yields of the PCR product from the tumor tissue to that from the corresponding non-tumor tissue (T/N) for the expression of IFNAR mRNAs were calculated. While the T/N ratio of IFNAR1 did not correlate with any factor, a high T/N ratio of IFNAR2 correlated with poor differentiation (P < 0.05), local invasion (P < 0.001), and metastasis (P < 0.0001). By multivariate analysis, a high T/N ratio of IFNAR2 predicted a shortened overall survival in all cases (P < 0.05) and a shorter disease-free survival in those without metastasis (M0; 68 cases, P < 0.05). Impressively, patients with a poorer response to IFN-alpha treatment had a higher IFNAR2 T/N ratio than those who had a good response (P < 0.05). IFNAR2c protein expression was higher in the primary tumors in patients with metastases (M1; 35 cases) compared to those without ( P < 0.0001).
CONCLUSION:
IFNAR2 is associated with the progression of RCC.
AuthorsTakao Kamai, Yoshiaki Yanai, Kyoko Arai, Hideyuki Abe, Tomonori Yamanishi, Masashi Kurimoto, Ken-Ichiro Yoshida
JournalBMC cancer (BMC Cancer) Vol. 7 Pg. 159 (Aug 15 2007) ISSN: 1471-2407 [Electronic] England
PMID17697365 (Publication Type: Journal Article)
Chemical References
  • IFNAR1 protein, human
  • IFNAR2 protein, human
  • Interferon-alpha
  • RNA, Messenger
  • Receptor, Interferon alpha-beta
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Blotting, Western
  • Carcinoma, Renal Cell (genetics, metabolism, secondary)
  • Female
  • Humans
  • Interferon-alpha (pharmacology)
  • Kidney Neoplasms (genetics, metabolism, pathology)
  • Male
  • Middle Aged
  • Prognosis
  • RNA, Messenger (genetics, metabolism)
  • Receptor, Interferon alpha-beta (genetics, metabolism)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Survival Rate

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: